WO2002028398A1 - Compositions destinees au traitement du diabete - Google Patents

Compositions destinees au traitement du diabete Download PDF

Info

Publication number
WO2002028398A1
WO2002028398A1 PCT/JP2001/008497 JP0108497W WO0228398A1 WO 2002028398 A1 WO2002028398 A1 WO 2002028398A1 JP 0108497 W JP0108497 W JP 0108497W WO 0228398 A1 WO0228398 A1 WO 0228398A1
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
treating diabetes
diabetes
treating
medicinal compositions
Prior art date
Application number
PCT/JP2001/008497
Other languages
English (en)
French (fr)
Inventor
Weidong Yin
Kazuhiko Tsutsumi
Original Assignee
Otsuka Pharmaceutical Factory, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory, Inc. filed Critical Otsuka Pharmaceutical Factory, Inc.
Priority to CA002422699A priority Critical patent/CA2422699C/en
Priority to JP2002532222A priority patent/JPWO2002028398A1/ja
Priority to US10/381,731 priority patent/US7001896B2/en
Priority to AU2001290305A priority patent/AU2001290305A1/en
Publication of WO2002028398A1 publication Critical patent/WO2002028398A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/JP2001/008497 2000-09-29 2001-09-28 Compositions destinees au traitement du diabete WO2002028398A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002422699A CA2422699C (en) 2000-09-29 2001-09-28 Compositions for treating diabetes
JP2002532222A JPWO2002028398A1 (ja) 2000-09-29 2001-09-28 糖尿病治療用組成物
US10/381,731 US7001896B2 (en) 2000-09-29 2001-09-28 Compositions for treating diabetes
AU2001290305A AU2001290305A1 (en) 2000-09-29 2001-09-28 Compositions for treating diabetes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPPCT/JP00/06741 2000-09-29
PCT/JP2000/006741 WO2002028397A1 (fr) 2000-09-29 2000-09-29 Medicaments anti-diabete

Publications (1)

Publication Number Publication Date
WO2002028398A1 true WO2002028398A1 (fr) 2002-04-11

Family

ID=11736541

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2000/006741 WO2002028397A1 (fr) 2000-09-29 2000-09-29 Medicaments anti-diabete
PCT/JP2001/008497 WO2002028398A1 (fr) 2000-09-29 2001-09-28 Compositions destinees au traitement du diabete

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/006741 WO2002028397A1 (fr) 2000-09-29 2000-09-29 Medicaments anti-diabete

Country Status (7)

Country Link
US (1) US7001896B2 (ja)
JP (1) JPWO2002028398A1 (ja)
CN (1) CN1232255C (ja)
AU (1) AU2001290305A1 (ja)
CA (1) CA2422699C (ja)
TW (1) TW592702B (ja)
WO (2) WO2002028397A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102813A1 (en) * 2001-06-20 2002-12-27 Merck Frosst Canada & Co. Aryldifluoromethylphosphonic acids for treatment of diabetes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05953A (ja) * 1990-11-27 1993-01-08 Otsuka Pharmaceut Factory Inc 白内障予防及び治療剤
JPH05170653A (ja) * 1991-12-25 1993-07-09 Otsuka Pharmaceut Factory Inc 糖尿病治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2787407B2 (ja) * 1992-06-19 1998-08-20 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05953A (ja) * 1990-11-27 1993-01-08 Otsuka Pharmaceut Factory Inc 白内障予防及び治療剤
JPH05170653A (ja) * 1991-12-25 1993-07-09 Otsuka Pharmaceut Factory Inc 糖尿病治療剤

Also Published As

Publication number Publication date
WO2002028397A1 (fr) 2002-04-11
TW592702B (en) 2004-06-21
CN1232255C (zh) 2005-12-21
JPWO2002028398A1 (ja) 2004-02-12
CA2422699C (en) 2009-08-11
AU2001290305A1 (en) 2002-04-15
CA2422699A1 (en) 2003-03-20
CN1454089A (zh) 2003-11-05
US7001896B2 (en) 2006-02-21
US20040014728A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
WO2003059372A3 (en) Combined use of a glp-1 compound and a modulator of diabetic late complications
IL151690A0 (en) Medicaments for complications of diabetes and neuropathy, and uses thereof
WO2002076499A3 (en) Combination treatment of pancreatic cancer
HUP0400823A3 (en) Heterocyclic compounds for treating aging-related and diabetic vascular complications, their preparation and pharmaceutical compositions containing them
EP1550456A3 (en) Use of botulinum toxin in the treatment of burn pain
WO2002064210A3 (en) Combination therapy comprising anti-diabetic and anticonvulsant agents
WO2000061192A3 (en) Methods and compositions for the treatment of pancreatitis
WO2002038129A3 (en) Delayed-release pharmaceutical formulations containing proinsulin c-peptide
MXPA02011722A (es) Composicion y aplicador para suministro de sustancias topicas.
EP1295609A4 (en) DRUGS CONTAINING COMBINED ACTIVE INGREDIENTS
WO2003051389A3 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
WO1999063976A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
CA2368574A1 (en) Compositions for preventing and treating type i allergy
WO2002094189A3 (en) Compositions and methods for treating or preventing convulsions or seizures
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
WO2002067886A3 (en) Skin composition
AU2000265109A1 (en) Method and compositions for prevention and/or treatment of diabetes and glucose modulation
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
WO2003035080A3 (en) A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
WO2001060343A3 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
WO2002028398A1 (fr) Compositions destinees au traitement du diabete
AU2001294221A1 (en) Preventives and remedies for complications of diabetes
WO2002087604A8 (de) Präparationen von vitamin e in kombination mit afamin
WO2001013907A3 (en) Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA JP KR MX RU SG US ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2422699

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10381731

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002532222

Country of ref document: JP

122 Ep: pct application non-entry in european phase